Skip to main content

FDA recall, , Moderate risk

Integra LifeSciences CUSA Clarity C7000 Console

The CUSA Clarity C7000 Console has a software issue that renders the touch screen unresponsive.

What happened

Integra LifeSciences Corp. (NeuroSciences) of Princeton, New Jersey recalled 78 units of the CUSA Clarity C7000 Console, Software Version 2.1.1.909, an ultrasonic surgical aspirator system, because of a software issue that renders the touch screen unresponsive. The recall began March 6, 2026 and was added to the FDA's Enforcement Report on April 17, 2026.

The product was distributed worldwide, including nationwide in the US states of Michigan and New York, and in Belgium, China, Czechia, Dubai, Finland, France, Germany, Italy, Japan, Luxembourg, Netherlands, Poland, Spain, Switzerland, Tunisia and the United Kingdom.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI matches.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. CUSA Clarity C7000 Console, Software Version: 2.1.1.909. Ultrasonic surgical aspirator system.

    UDI-DI
    • 10381780126232

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Michigan & New York. The countries of Belgium, China, Czechia, Dubai, Finland, France, Germany, Italy, Japan, Luxembourg, Netherlands. Poland, Spain, Switzerland, Tunisia & United Kingdom.

Company
Integra LifeSciences Corp. (NeuroSciences)Princeton, New Jersey
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98476
Recall number
Z-1828-2026
Quantity recalled
78 units

All recalls from Integra LifeSciences Corp. (NeuroSciences)

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)